Table 2 HBeAg prevalence among HBsAg-positive females %, 2005

Asia Pacific (high income)

64.44

46.32

34.92

25.63

16.30

12.71

12.95

14.85

17.02

17.98

Central Asia

60.52

43.08

31.78

24.12

16.31

12.53

11.67

12.17

12.98

13.39

East Asia

68.72

49.16

36.10

27.31

18.35

14.01

13.00

13.53

14.51

15.05

South Asia

46.35

35.83

28.20

21.77

14.82

11.42

10.67

11.12

11.81

12.09

South East Asia

66.56

47.73

35.42

26.85

18.10

13.91

13.04

13.66

14.56

14.97

Australasia

64.00

45.86

33.89

25.64

17.38

13.49

12.61

13.08

13.92

14.34

Caribbean

58.69

43.00

31.85

24.14

16.31

12.60

11.78

12.24

13.04

13.45

Central Europe

59.04

42.85

31.91

24.21

16.33

12.55

11.73

12.29

13.13

13.51

Eastern Europe

59.18

42.97

31.87

24.15

16.34

12.64

11.75

12.17

12.89

13.23

Western Europe

63.58

41.39

29.24

22.20

15.61

12.66

12.21

12.90

13.85

14.27

Andean LA

59.42

43.02

31.77

24.08

16.27

12.52

11.70

12.27

13.16

13.54

Central LA

59.11

42.95

31.95

24.26

16.44

12.65

11.74

12.16

12.94

13.34

Southern LA

63.24

45.71

33.89

25.79

17.66

13.74

12.63

12.72

13.08

13.22

Tropical LA

59.85

43.30

31.51

24.08

17.01

13.65

12.06

11.03

10.19

9.79

North Africa and Middle East

52.12

37.62

28.09

21.60

14.98

11.73

11.02

11.41

12.03

12.34

North America (high income)

63.05

45.98

33.91

25.73

17.49

13.47

12.53

12.97

13.74

14.15

Oceania

67.25

47.89

35.66

27.09

18.32

14.11

13.24

13.80

14.53

14.84

Central Sub-Saharan Africa

54.86

40.20

29.98

22.70

15.28

11.73

11.03

11.62

12.44

12.82

East Sub-Saharan Africa

55.50

39.96

30.14

22.96

15.56

12.06

11.22

11.65

12.39

12.72

Southern Sub-Saharan Africa

54.73

36.79

26.90

21.20

15.11

11.87

11.07

11.52

12.30

12.66

West Sub-Saharan Africa

55.32

41.07

30.60

23.17

15.50

11.86

11.06

11.65

12.55

12.95